Effortless Measurement of All Four NADs and Glutathione for Laboratories

NADMED has announced an innovative technology designed for effortless extracting and measuring all four NADs and two glutathiones.

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials

First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial

Lixe Biotechnology announced the dosing of the first patient in its Phase 1b/2 clinical trial to assess the efficacy of its LB-100 lead molecule with GSK's PD-1-blocking monoclonal antibody, dostarlimab-gxly, in the treatment of ovarian clear cell carcinoma.

AppOmni Harnesses Google Data Center in Australia to Address Regional Demand for Specialised SaaS Security Solutions

AppOmni, the pioneer of SaaS security posture management (SSPM), proudly announces the establishment of a new data centre in Sydney, Australia, hosted by Google Cloud Platform (GCP). This new initiative brings AppOmni’s comprehensive SaaS security solutions to any organisation—private or public—required to comply with Australia’s data sovereignty regulations, including the Privacy Act and the Australian Privacy Principles. As AppOmni continues its global expansion efforts, Australia remains a strategic location for the company. The new data centre helps address a growing need in the APAC region to counter sophisticated threats targeting SaaS applications. These concerns are echoed by the 25% of Fortune 100 companies that already trust AppOmni to secure their SaaS ecosystems.

Watson-Marlow to demonstrate latest fluid path technologies at MD&M West

Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.

ZeOmega Partners With Datycs to Digitize Faxed Documents and Automate Healthcare Data Workflows

This collaboration allows payers to make processes such as prior authorization more efficient; especially critical given the new requirements for faster turnaround times. Digitizing faxed documents and applying technologies such as AI and NLP to mine data cuts back on manual steps, reducing administrative burden and costs.

Currax Pharmaceuticals Announces First Patient Screened into the INFORMUS Cardiovascular Outcomes Trial

Currax Pharmaceuticals announces the first patient screened and accepted into the CONTRAVE® INFORMUS Cardiovascular Outcomes Trial (NB-CVOT3).

Lactocore Group leverages milk peptides to combat inflammaging

Body-wide inflammation is linked to many chronic diseases, affecting health and longevity. Recent data indicates that milk protein hydrolysate is a promising source of novel bioactive peptides. These peptides have potential application in correcting inflammaging and age-associated metabolic disorders

Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery

Vector Laboratories and Navinci Diagnostics announced that they have signed an agreement to develop cutting-edge biomarker discovery tools, allowing detection of specific protein glycosylation in tissue samples.

Creative Biogene Debuts Revolutionary Single Cell CRISPR Library Screening Services

Qlucore Diagnostics for Pediatric leukemia takes a Significant step closer to CE marking

Qlucore, a leader in software development for precision cancer diagnostics, has taken the final major step in the process towards a CE-marked medical device for in-vitro diagnostics by submitting the technical documentation to a Notified Body. The CE marked product, Qlucore Diagnostics, is due to be launched in February 2025.

Transformative Impact of AR and VR Technologies in Healthcare Amidst the COVID-19 Pandemic

The COVID-19 pandemic has acted as a catalyst for the integration of AR and VR technologies in the healthcare industry. From training healthcare professionals to addressing staff shortages, educating patients, and facilitating treatment and rehabilitation, these immersive technologies have proven their worth in navigating the complexities of the ongoing global health crisis. As the world continues to grapple with the challenges posed by the pandemic, the role of AR and VR in healthcare is likely to evolve and expand, ushering in a new era of innovation and resilience in the face of health emergencies.

Creative Enzymes Revolutionizes the Field with Advanced Industrial Enzyme Production Service

Creative Enzymes Introduces Pyranose Oxidase from Microorganism for Enhanced Industrial Applicability

Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release

Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare.

Creative Proteomics Offers Advanced Steroids Analysis Service for Medical Industry

CD BioSciences Releases Analysis of Marine Organisms to Drive Marine Bioresearch Forward

CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.

Creative Proteomics Bolsters Its Position in Biomarker Discovery with N-Glycan and O-Glycan Profiling Services

Creative Proteomics Amplifies Its Services with High-precision Amino Acid Analysis

Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston

Recognizing the critical role of artificial intelligence in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event.